Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Nix

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Antimicrobial Agents and Chemotherapy|August 1, 1995
In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosaJ M Hyatt, D E Nix, C W Stratton, et al.
The Annals of Pharmacotherapy|November 29, 2001
Pharmacokinetics of para-aminosalicylic acid granules under four dosing conditionsC A Peloquin, M Zhu, R D Adam, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
Pharmacokinetics of ethionamide administered under fasting conditions or with orange juice, food, or antacidsB Auclair, D E Nix, R D Adam, et al.
The American Journal of Medicine|April 27, 1987
Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokineticsD E Nix, T J Cumbo, P Kuritzky, et al.
Pharmacotherapy|November 23, 2001
Pharmacokinetics of cycloserine under fasting conditions and with high-fat meal, orange juice, and antacidsM Zhu, D E Nix, R D Adam, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacinA Forrest, C H Ballow, D E Nix, et al.
The Journal of Trauma|November 22, 2000
Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimensJ F Barletta, S B Johnson, D E Nix, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1993
Effect of oral antacids on disposition of intravenous enoxacinD E Nix, M E Lebsack, M Chapelsky, et al.
Archives of Internal Medicine|October 1, 1989
Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradicationC A Peloquin, T J Cumbo, D E Nix, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1991
Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaningD E Nix, S D Goodwin, C A Peloquin, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|August 1, 1995
In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosaJ M Hyatt, D E Nix, C W Stratton, et al.
The Annals of Pharmacotherapy|November 29, 2001
Pharmacokinetics of para-aminosalicylic acid granules under four dosing conditionsC A Peloquin, M Zhu, R D Adam, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
Pharmacokinetics of ethionamide administered under fasting conditions or with orange juice, food, or antacidsB Auclair, D E Nix, R D Adam, et al.
The American Journal of Medicine|April 27, 1987
Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokineticsD E Nix, T J Cumbo, P Kuritzky, et al.
Pharmacotherapy|November 23, 2001
Pharmacokinetics of cycloserine under fasting conditions and with high-fat meal, orange juice, and antacidsM Zhu, D E Nix, R D Adam, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacinA Forrest, C H Ballow, D E Nix, et al.
The Journal of Trauma|November 22, 2000
Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimensJ F Barletta, S B Johnson, D E Nix, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1993
Effect of oral antacids on disposition of intravenous enoxacinD E Nix, M E Lebsack, M Chapelsky, et al.
Archives of Internal Medicine|October 1, 1989
Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradicationC A Peloquin, T J Cumbo, D E Nix, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1991
Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaningD E Nix, S D Goodwin, C A Peloquin, et al.
Pageof 8